LSLuciane Valéria Sita

Luciane Valéria Sita

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Luciane Valéria Sita has a total of 99 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Norepinephrine and glucocorticoids modulate chronic unpredictable stress-induced increase in the type 2 CRF and glucocorticoid receptors in brain structures related to the HPA axis activation

    by Marilia B Malta, Joelcimar Martins, Leonardo S Novaes, Nilton B dos Santos, Luciane Sita, Rosana Camarini, Cristoforo Scavone, Jackson Bittencourt, Carolina D. Munhoz

    The stress response is multifactorial and enrolls circuitries to build a coordinated reaction, leading to behavioral, endocrine, and autonomic changes. These changes are mainly related to the hypothalamus-pituitary-adrenal (HPA) axis activation and the organism’s integrity. However, when self-regulation is ineffective, stress becomes harmful and predisposes the organism to pathologies. The chronic unpredictable stress (CUS) is a widely used experimental model since it induces physiological and behavioral changes and better mimics the stressors variability encountered in daily life. Corticotropin-releasing factor (CRF) and glucocorticoid (GCs) are deeply implicated in the CUS-induced physiological and behavioral changes. Nonetheless, the CUS modulation of CRF receptors and GR and the norepinephrine role in extra-hypothalamic brain areas were not well explored. Here, we show that 14-days of CUS induced a long-lasting HPA axis hyperactivity evidenced by plasmatic corticosterone increase and adrenal gland hypertrophy, which was dependent on both GCs and NE release induced by each stress session. CUS also increased CRF 2 mRNA expression and GR protein levels in fundamental brain structures related to HPA regulation and behavior, such as the lateral septal nucleus intermedia part (LSI), ventromedial hypothalamic nucleus (VMH), and central nucleus of the amygdala (CeA). We also showed that NE participates in the CUS-induced increase in CRF 2 and GR levels in the LSI, reinforcing the locus coeruleus (LC) involvement in the HPA axis modulation. Despite the CUS-induced molecular changes in essential areas related to anxiety-like behavior, this phenotype was not observed in CUS animals 24 h after the last stress session. Highlights: CUS persistently increased plasma CORT levels via GCs and NE signaling. CUS persistently increased CRF 2 mRNA in extra-hypothalamic brain areas. CUS increased GR protein levels in brain regions related to GCs release control. NE and GCs participate in the CUS-induced increase in CRF 2 and GR levels. LSI could be the brain nucleus that dictates the fine-tuned response of CUS. CUS animals did not present anxiety-like behavior.

  • Open Access

    The Rat Mammary Gland as a Novel Site of Expression of Melanin-Concentrating Hormone Receptor 1 mRNA and Its Protein Immunoreactivity

    by Daniella S. Battagello, Aline R. Lorenzon, Giovanne B. Diniz, Lívia C. Motta-Teixeira, Marianne O. Klein, Jozélia G. P. Ferreira, Carlos M. Arias, Antoine Adamantidis, Luciane V. Sita, José Cipolla-Neto, et al.

    Lactation is a complex physiological process, depending on orchestrated central and peripheral events, including substantial brain plasticity. Among these events is a novel expression of pro-melanin-concentrating hormone (Pmch) mRNA in the rodent hypothalamus, such as the ventral part of the medial preoptic area (vmMPOA). This expression reaches its highest levels around postpartum day 19 (PPD19), when dams transition from lactation to the weaning period. The appearance of this lactation-related Pmch expression occurs simultaneously with the presence of one of the Pmch products, melanin-concentrating hormone (MCH), in the serum. Given the relevance of the MPOA to maternal physiology, and the contemporaneity between Pmch expression in this structure and the weaning period, we hypothesized that MCH has a role in the termination of lactation, acting as a mediator between central and peripheral changes. To test this, we investigated the presence of the MCH receptor 1 (MCHR1) and its gene expression in the mammary gland of female rats in different stages of the reproductive cycle. To that end, in situ hybridization, RT-PCR, RT-qPCR, nucleotide sequencing, immunohistochemistry and western blotting were employed. While Mchr1 expression was detected in the epidermis and dermis of both diestrus and lactating rats, parenchymal expression was exclusively found in the functional mammary gland of lactating rats. The expression of Mchr1 mRNA oscillated through lactation period and reached its maximum in PPD19 dams. Presence of MCHR1 was confirmed with immunohistochemistry, with preferential location of MCHR1 immunoreactive cells in the alveolar secretory cells. As was the case for gene expression, the MCHR1 protein levels were significantly higher in PPD19 than in other groups. Our data demonstrate the presence of an anatomical basis for the participation of MCH peptidergic system on the control of lactation through the mammary gland, suggesting that MCH could modulate a pro-lactation action in early postpartum days and the opposite role at the end of the lactation.


  • Ciliary melanin‐concentrating hormone receptor 1 (MCHR1) is widely distributed in the murine CNS in a sex‐independent manner

    by Giovanne B. Diniz, Daniella S. Battagello, Marianne O. Klein, Bianca S. M. Bono, Jozélia G. P. Ferreira, Livia C. Motta‐Teixeira, Jessica C. G. Duarte, Françoise Presse, Jean‐Louis Nahon, Antoine Adamantidis, et al.

    Melanin‐concentrating hormone (MCH) is a ubiquitous vertebrate neuropeptide predominantly synthesized by neurons of the diencephalon that can act through two G protein‐coupled receptors, called MCHR1 and MCHR2. The expression of Mchr1 has been investigated in both rats and mice, but its synthesis remains poorly described. After identifying an antibody that detects MCHR1 with high specificity, we employed immunohistochemistry to map the distribution of MCHR1 in the CNS of rats and mice. Multiple neurochemical markers were also employed to characterize some of the neuronal populations that synthesize MCHR1. Our results show that MCHR1 is abundantly found in a subcellular structure called the primary cilium, which has been associated, among other functions, with the detection of free neurochemical messengers present in the extracellular space. Ciliary MCHR1 was found in a wide range of areas, including the olfactory bulb, cortical mantle, striatum, hippocampal formation, amygdala, midline thalamic nuclei, periventricular hypothalamic nuclei, midbrain areas, and in the spinal cord. No differences were observed between male and female mice, and interspecies differences were found in the caudate‐putamen nucleus and the subgranular zone. Ciliary MCHR1 was found in close association with several neurochemical markers, including tyrosine hydroxylase, calretinin, kisspeptin, estrogen receptor, oxytocin, vasopressin, and corticotropin‐releasing factor. Given the role of neuronal primary cilia in sensing free neurochemical messengers in the extracellular fluid, the widespread distribution of ciliary MCHR1, and the diverse neurochemical populations who synthesize MCHR1, our data indicate that nonsynaptic communication plays a prominent role in the normal function of the MCH system.


  • Open Access

    Cover Image, Volume 527, Issue 18

    by Giovanne B. Diniz, Daniella S. Battagello, Pedro M. Cherubini, Julio D. Reyes‐Mendoza, Cesar Luna‐Illades, Marianne O. Klein, Lívia C. Motta‐Teixeira, Luciane V. Sita, Manuel Miranda‐Anaya, Teresa Morales, et al.

  • Open Access

    The distribution of neuronal primary cilia immunoreactive to melanin-concentrating hormone receptor 1 (MCHR1) in the murine prosencephalon

    by Giovanne B. Diniz, Daniella S. Battagello, Bianca S. M. Bono, Jozélia G. P. Ferreira, Marianne O. Klein, Livia C. Motta-Teixeira, Jessica C. G. Duarte, Françoise Presse, Jean-Louis Nahon, Antoine Adamantidis, et al.

    Melanin-concentrating hormone (MCH) is a ubiquitous vertebrate neuropeptide predominantly synthesized by neurons of the diencephalon that can act through two G protein-coupled receptors, called MCHR1 and MCHR2. The expression of Mchr1 has been investigated in both rats and mice, but its synthesis remains poorly described. After identifying an antibody that detects MCHR1 with high specificity, we employed immunohistochemistry to map the distribution of MCHR1 in the CNS of rats and mice. Multiple neurochemical markers were also employed to characterize some of the neuronal populations that synthesize MCHR1. Our results show that MCHR1 is abundantly found in a sensory subcellular structure called the neuronal primary cilium , which has been associated with the detection of free neurochemical agents released to act through volume transmission. Ciliary MCHR1 was found in a wide range of areas, including the olfactory bulb, cortical mantle, striatum , hippocampal formation, amygdala, midline thalamic nuclei, periventricular hypothalamic nuclei, and midbrain areas. No differences were observed between male and female mice, and rats and mice diverged in two key areas: the caudate-putamen nucleus and the subgranular zone of the dentate gyrus. Ciliary MCHR1 was found in close association to several neurochemical markers, including tyrosine hydroxylase, calretinin, kisspeptin, estrogen receptor, oxytocin, vasopressin, and corticotropin-releasing factor. Given the role of neuronal primary cilia in sensing free neurochemical messengers in the extracellular fluid, the widespread distribution of ciliary MCHR1, and the diverse neurochemical populations who synthesize MCHR1, our data indicates that volume transmission may play a prominent role in the normal function of the MCH system.

    • 30 June 2019
      • Vol. 17  (2) , A153-A158

    Development of Low-Cost Tactile Neuroanatomy Learning Tools for Students With Visual-Impairment.

    by Giovanne B Diniz, Luciane V Sita

    Visual impairment is the most common form of disability in the world and results in major challenges to the education and employment of affected individuals. It is important, therefore, to provide the best possible higher education for these individuals, not only providing the same access to theoretical contents but also training them for their future work environment. The reliance of neuroanatomy teaching on visual material creates a set of challenges for educators, a situation that is only worsened by the lack of specific neuroanatomy teaching tools for students with visual impairment. To overcome this problem, a set of tactile tools for neuroanatomy education was prepared using low-cost materials such as hot-melt adhesive, pins and easily found fabrics. These tools were then employed in an undergraduate class of physical therapy, speech therapy and occupational therapy students that included a student with visual impairment. The use of tactile tools allowed full integration of the student, who was able to participate in hands-on classes with her peers. We anticipate that the ease of fabrication and the low cost may allow this experience to be replicated in the instruction of neuroanatomy in undergraduate neuroscience programs at other institutions.


  • Melanin‐concentrating hormone peptidergic system: Comparative morphology between muroid species

    by Giovanne B. Diniz, Daniella S. Battagello, Pedro M. Cherubini, Julio D. Reyes‐Mendoza, Cesar Luna‐Illades, Marianne O. Klein, Lívia C. Motta‐Teixeira, Luciane V. Sita, Manuel Miranda‐Anaya, Teresa Morales, et al.

    Melanin‐concentrating hormone (MCH) is a conserved neuropeptide, predominantly located in the diencephalon of vertebrates, and associated with a wide range of functions. While functional studies have focused on the use of the traditional mouse laboratory model, critical gaps exist in our understanding of the morphology of the MCH system in this species. Even less is known about the nontraditional animal model Neotomodon alstoni (Mexican volcano mouse). A comparative morphological study among these rodents may, therefore, contribute to a better understanding of the evolution of the MCH peptidergic system. To this end, we employed diverse immunohistochemical protocols to identify key aspects of the MCH system, including its spatial relationship to another neurochemical population of the tuberal hypothalamus, the orexins. Three‐dimensional (3D) reconstructions were also employed to convey a better sense of spatial distribution to these neurons. Our results show that the distribution of MCH neurons in all rodents studied follows a basic plan, but individual characteristics are found for each species, such as the preeminence of a periventricular group only in the rat, the lack of posterior groups in the mouse, and the extensive presence of MCH neurons in the anterior hypothalamic area of Neotomodon. Taken together, these data suggest a strong anatomical substrate for previously described functions of the MCH system, and that particular neurochemical and morphological features may have been determinant to species‐specific phenotypes in rodent evolution.


  • Open Access

    Nomenclature and Comparative Morphology of the Teneurin/TCAP/ADGRL Protein Families

    by Luciane Valéria Sita, Giovanne Baroni Diniz, José De Anchieta C Horta Junior, Claudio Aparecido Casatti, Jackson Cioni Bittencourt

    The teneurins are a family of glycosylated type II transmembrane proteins synthesized in several tissue from both vertebrate and invertebrate species. These proteins interact with the latrophilins, a group of adhesion G protein-coupled receptors. Both teneurins and latrophilins may have been acquired by choanoflagellates through horizontal gene transfer from a toxin-target system present in prokaryotes. Teneurins are highly conserved in eukaryotes, with four paralogs (TEN1, TEN2, TEN3 and TEN4) in most vertebrates playing a role in the normal neural development, axonal guiding, synapse formation and synaptic maintenance. In this review, we summarize the main findings concerning the distribution and morphology of the teneurins and latrophilins, both during development and in adult animals. We also briefly discuss the current knowledge in the distribution of the teneurin C-terminal associated protein (TCAP), a peptidergic sequence at the terminal portion of teneurins that may be independently processed and secreted. Through the analysis of anatomical data, we drew parallels to the evolution of those proteins and the increasing complexity of this system, which mirrors the increase in sensory complexity. This review underscores the need for further studies investigating the distribution of teneurins and latrophilins and the use of different animal models.


  • Characterisation and origins of melanin‐concentrating hormone immunoreactive fibres of the posterior lobe of the pituitary and median eminence during lactation in the Long‐Evans rat

    by Helder C. Costa, Joelcimar M. Da‐Silva, Giovanne B. Diniz, Livia C. Motta‐Teixeira, Renata J. Da‐Silva, Daniella S. Battagello, Luciane V. Sita, Carla De‐Moraes Machado, José A. C. Horta‐Júnior, Jackson C. Bittencourt

    While the melanin‐concentrating hormone [MCH] and its coding mRNA are predominantly found in the tuberal hypothalamus, there is detectable synthesis of MCH in the preoptic hypothalamus exclusively in lactating dams, suggesting a participation of MCH in the alterations that take place after parturition. Also implicated in the dam physiology is oxytocin, a neurohormone released from the posterior pituitary that is necessary for milk ejection. Since the projection fields from oxytocin‐immunoreactive neurons and the mediobasal preoptic hypothalamus overlap and MCH‐ir neurons are found in proximity to oxytocin neurons, we investigated the spatial relationship between MCH and oxytocin fibers. To that end, we employed multiple immunohistochemistry labeling for MCH and oxytocin for light and electron microscopy techniques, in addition to intravenous tracer injection combined to in situ hybridization to identify MCH neurons that project to neurosecretory areas. As described for other strains, lactating Long‐Evans dams also display immunoreactivity for MCH in the preoptic hypothalamus on the 12th and 19th days of lactation. The appearance of these neurons is contemporaneous with an increase in MCH‐immunoreactive fibers in both the internal layer of the median eminence and the posterior pituitary. In both regions, MCH‐ and oxytocin‐immunoreactive fibers were found in great proximity, but there was no evidence for synaptic interaction between these two populations at the ultrastructural level. The tracer injection revealed that only mediobasal preoptic MCH neurons project to the posterior pituitary, suggesting a neuroendocrine‐modulatory role for this population. When taken together, our results indicate that neuroplasticity events at the mediobasal preoptic hypothalamus that occur during late lactation may be part of a neuroendocrinology control loop involving both MCH and oxytocin.


  • Open Access

    Anatomical Organization of Urocortin 3-Synthesizing Neurons and Immunoreactive Terminals in the Central Nervous System of Non-Human Primates [Sapajus spp.]

    by Daniella S. Battagello, Giovanne B. Diniz, Paulo L. Candido, Joelcimar M. da Silva, Amanda R. de Oliveira, Kelly R. Torres da Silva, Claudimara F. P. Lotfi, José A. de Oliveira, Luciane V. Sita, Cláudio A. Casatti, et al.

    Urocortin 3 [UCN3] is a neuropeptide member of the corticotrophin-releasing factor [CRF] peptide family that acts as a selective endogenous ligand for the CRF2 receptor. Immunohistochemistry and in situ hybridization data from rodents revealed UCN3-containing neurones in discrete regions of the CNS, such as the medial preoptic nucleus, the rostral perifornical area, the medial nucleus of the amygdala and the superior paraolivary nucleus. UCN3-immunoreactive [UCN3-ir] terminals are distributed throughout regions that mostly overlap with regions of CRF2 mRNA expression. Currently, no similar mapping exists for non-human primates. To better understand the role of this neuropeptide, we aimed to study the UCN3 distribution in the brains of New World monkeys of the Sapajus genus. To this end, we analysed the gene and peptide sequences in these animals and performed immunohistochemistry and in situ hybridization to identify UCN3 synthesis sites and to determine the distribution of UCN3 immunoreactive terminals. The sequencing of the Sapajus spp. UCN3-coding gene revealed 88% and 65% identity to the human and rat counterparts, respectively. Additionally, using a probe generated from monkey cDNA and an antiserum raised against human UCN3, we found that labelled cells are mainly located in the hypothalamic and limbic regions. UCN3-ir axons and terminals are primarily distributed in the ventromedial hypothalamic nucleus and the lateral septal nucleus. Our results demonstrate that UCN3-producing neurones in the CNS of monkeys are phylogenetically conserved compared to those of the rodent brain, that the distribution of fibres agrees with the distribution of CRF2 in other primates and that there is anatomical evidence for the participation of UCN3 in neuroendocrine control in primates.